Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Other Non Operating Income (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Other Non Operating Income for 4 consecutive years, with $4000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income fell 99.28% year-over-year to $4000.0, compared with a TTM value of -$74000.0 through Sep 2025, down 112.23%, and an annual FY2024 reading of $528000.0, up 314.63% over the prior year.
  • Other Non Operating Income was $4000.0 for Q3 2025 at Atara Biotherapeutics, down from $22000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $555000.0 in Q3 2024 and bottomed at -$1.7 million in Q4 2022.
  • Average Other Non Operating Income over 4 years is -$98466.7, with a median of -$11000.0 recorded in 2025.
  • Peak annual rise in Other Non Operating Income hit 2155.56% in 2024, while the deepest fall reached 641.67% in 2024.
  • Year by year, Other Non Operating Income stood at -$1.7 million in 2022, then soared by 99.3% to -$12000.0 in 2023, then tumbled by 641.67% to -$89000.0 in 2024, then surged by 104.49% to $4000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for ATRA at $4000.0 in Q3 2025, $22000.0 in Q2 2025, and -$11000.0 in Q1 2025.